AST SpaceMobile: Manufacturing Scales, But Launch Risk Keeps Thesis on Hold

What happened

AST SpaceMobile shares have dropped 56% from their 2026 peak even as the company reports manufacturing progress through BlueBird 46 and a target of six satellites per month. The Seeking Alpha piece argues that deploying approximately 45 satellites by early 2027 will unlock commercial coverage and that the carrier-centric model protects against SpaceX. But the earnings data tell a less rosy story: no SpaceMobile Service revenue has launched, only 6.6% of the $1.2B backlog is expected to convert in the next 12 months, and launch availability remains outside management's control. The decline suggests the market is no longer willing to pay for unproven scale. The next 30 satellites only matter if they actually reach orbit on schedule and monetize quickly.

Implication

The next 30 satellites are necessary but not sufficient for value creation; without confirmed launch windows and paid carrier service, the stock remains a speculative bet on execution. The manufacturing ramp de-risks supply but not demand or orbit access, and SpaceX's aggressive rollout adds competitive pressure. The master report's WAIT rating remains appropriate, with a trim above $80 and attractive entry at $50. If the stock falls further toward the $50 level, it would start to price in more realistic scenarios, but for now, the risk/reward is not compelling. Any new financing before service revenue would be a negative signal.

Thesis delta

The thesis is unchanged: WAIT. The news strengthens the manufacturing pillar but does not alter the core uncertainties of launch availability and commercial activation. The stock's 56% decline suggests the market is catching up to our cautious view, but we need hard evidence of cadence and service launch before upgrading.